Zobrazeno 1 - 10
of 182
pro vyhledávání: '"M, Gellai"'
Publikováno v:
Molecular and Cellular Biochemistry. 197:53-59
Neutral endopeptidase (NEP, 24.11) is an ectoenzyme involved in the degradation of peptide hormones such as endothelin (ET), atrial natriuretic factor and enkephalins. The current study was designed to assess the involvement of NEP in ischemia-induce
Publikováno v:
Journal of Cardiovascular Pharmacology. 26:S322-325
Binding studies performed in dog kidney, lung, and spleen using [125I]endothelin (ET) 3 and a series of ETB-selective ligands indicated the presence of two subtypes of ETB receptors, an IRL-1620-sensitive (putative ETB1) and an IRL-1620-insensitive (
Autor:
D. E. Allen, M. Gellai
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 265:R689-R696
Renal alpha 2-adrenoreceptors modulate the hydrosmotic action of arginine vasopressin (AVP) through suppression of AVP-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) accumulation. Circulating catecholamines, likely candidates for the endogeno
Publikováno v:
Fundamental & Clinical Pharmacology. 5:25-38
The mechanism(s) responsible for arterial vasodilation observed following acute administration of racemic carvedilol, a novel vasodilator/beta adrenoceptor antagonist, has been investigated in rats. In conscious spontaneously hypertensive rats, carve
Autor:
D. E. Allen, M. Gellai
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 258:R1034-R1041
We evaluated the effects of leukotrienes (LTs) C4 and D4 on systemic and renal hemodynamics in conscious rats. Intravenous injections of LTC4 or LTD4 (0.5-10 micrograms/kg) caused dose-dependent decreases in cardiac output (CO), renal blood flow (RBF
Publikováno v:
European Journal of Clinical Pharmacology. 38:S82-S88
Carvedilol is a potent antihypertensive agent with a dual mechanism of action. At relatively low concentrations it is a competitive β-adrenoceptor antagonist and a vasodilator, whereas at higher concentrations it is also a calcium channel antagonist
Publikováno v:
Biochemical and Biophysical Research Communications. 241:212-214
In this study, the involvement of osteopontin in a rat model of ischemia-induced acute renal failure (ARF) was evaluated. In unilaterally nephrectomized Sprague Dawley rats where the left artery was occluded for 30 min., plasma creatinine levels incr
Publikováno v:
Molecular and cellular biochemistry. 197(1-2)
Neutral endopeptidase (NEP, 24.11) is an ectoenzyme involved in the degradation of peptide hormones such as endothelin (ET), atrial natriuretic factor and enkephalins. The current study was designed to assess the involvement of NEP in ischemia-induce
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 286(3)
Administration of the selective adenosine A1 receptor antagonist, CVT-124, to conscious chronically instrumented rats resulted in significant increases in urine flow rate and sodium excretion without affecting potassium excretion or renal hemodynamic
Autor:
E H, Ohlstein, P, Nambi, D W, Hay, M, Gellai, D P, Brooks, J, Luengo, J N, Xiang, J D, Elliott
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 286(2)
The present study describes the pharmacological profile of ((E)-alpha-[[1-butyl-5-[2-[(2-carboxyphenyl)methoxy]-4-methoxy-phenyl ]-1H-pyrazol-4-yl]methlene]-6-methoxy-1,3-benzodioxole-5-propanoic acid) (SB 234551), a high-affinity, nonpeptide endothe